Skip to main content
. 2021 Oct 29;46(2):333–341. doi: 10.1038/s41366-021-01005-y

Fig. 5. Cross-talk between adiposity, weight loss and CRC risk.

Fig. 5

AGO2 communicates with DELTA133P53, CCNE1 and STAT3 in obese patients to potentially mediate increased CRC risk via increased inflammation. AGO2 communicates with DELTA133P53 and CCNE1 in non-obese patients following RYGB to potentially mediate reduced CRC risk via reduced inflammation.